> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# International Labs Recalls Mislabeled Pravastatin
- URL: https://www.fdaweb.com/international-labs-recalls-mislabeled-pravastatin-2/
- Published: 2017-08-14T12:00:00.000Z
- Updated: 2026-09-14T22:40:58.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5139379

International Laboratories has recalled one lot of pravastatin sodium tablets USP 40 mg packaged in bottles of 30 tablets due to mislabeling. The product is labeled as pravastatin sodium but the lot contained bupropion hydrochloride 300 mg tablets. “If a subject mistakenly takes bupropion, common side effects include: nausea, vomiting, dry mouth, headache, constipation, sweating, sore throat, diarrhea, dizziness, restlessness, blurry vision,” a [recall notice](http://links.govdelivery.com/track?type=click&enid=ZWFzPTEmbWFpbGluZ2lkPTIwMTcwODEwLjc2ODcwNjAxJm1lc3NhZ2VpZD1NREItUFJELUJVTC0yMDE3MDgxMC43Njg3MDYwMSZkYXRhYmFzZWlkPTEwMDEmc2VyaWFsPTE3NDM5ODczJmVtYWlsaWQ9ZGF2aWRAZmRhd2ViLmNvbSZ1c2VyaWQ9ZGF2aWRAZmRhd2ViLmNvbSZmbD0mZXh0cmE9TXVsdGl2YXJpYXRlSWQ9JiYm&&&102&&&https://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm571066.htm?source=govdelivery&utm%5Fmedium=email&utm%5Fsource=govdelivery) says. “However, individuals with epilepsy are at higher risk of seizure on bupropion due to it lowering the seizure threshold. Also, people on MAOIs can have a risky drug interaction with bupropion (hypertensive crisis).”